Skip to content
Pfizer says clinical trial shows their candidate RSV maternal vaccine protects the baby
Pfizer announced yesterday that results from the Phase 3 clinical trial of its ...
Read More
Tech solutions needed to boost farm productivity, USDA economists say
U.S. farm productivity continues to grow, but the pace is slowing due to ...
Read More
Industry, regulators opening their minds to psychedelics as treatments
Scientific and commercial acceptance of the use of psychedelics as treatments for PTSD, ...
Read More
Meet Rachel King, BIO’s new interim CEO and a champion of the biotech industry
Rachel King was enjoying her retirement. When the COVID-19 pandemic hit, King found ...
Read More
RSV, COVID, and flu ‘tripledemic’ risk runs high
As the weather is getting colder with the winter months approaching, the very ...
Read More
This Halloween, biotech is making your candy haul more sustainable
According to the National Confectioners Association (NCA), 93% of Americans plan to celebrate ...
Read More
EDITORS' CHOICE
Congressional commission urges support in U.S.-China competition for biotech dominance
Maintaining biotechnology superiority is essential to the U.S. economy and national security, and it must be supported with strategic federal funding that leans into America’s ...
Read More
LATEST NEWS
Federal Policy
Nkarta’s Hastings discusses environment for biotech funding in Endpoints panel
Speaking on a recent Endpoints News panel, Nkarta CEO Paul Hastings discussed the impact of regulatory uncertainty and federal funding cuts on the investment climate ...
Federal Policy
U.S. leadership in rare disease drugs at risk, BIO expert tells Orphan Drug Congress
America has long been the global leader in rare disease drug development but this leadership is at risk unless Congress protects key incentives In 1983, ...
Agriculture
BIO applauds reintroduction of two bills aimed at patent reform
The May 1 reintroduction of two bills designed to strengthen the certainty of U.S. patents earned praise from the Biotechnology Innovation Organization (BIO). The Patent ...
Federal Policy
BIO report outlines use of NAMs to reduce animal testing
Safeguarding human health during clinical research is critically important, but biotechnology has shown that this does not always have to mean using animals to test ...
Health
Q1 roundup of state health policy impacting biotech
State legislatures remain busy across the country—especially when it comes to healthcare policy. As Q1 wraps up and we move into the mid-year, the Biotechnology ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
Climate Change
Combatting misinformation on biotechnology in food
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand ...
Read More
Federal Policy
State Policy
Q1 roundup of state health policy impacting biotech
State legislatures remain busy across the country—especially when it comes to healthcare policy. As Q1 wraps up and we move ...
Read More
International
Bio's View
BIO campaign urges: ‘Invest in America. Vaccinate’
Now that vaccines have all but eliminated smallpox, measles, polio, and other childhood scourges in the U.S., it seems easy ...
Read More
